Schering Ag Articles
ROUND-UP OF 1993'S NEW CHEMICAL ENTITIES
31 January 1994
EUROPEAN STOCK COMMENT
24 January 1994
LIKELY IMPACT ON DRUG FIRMS OF ITALIAN REFORMS
17 January 1994
CHANGES AT NOVO NORDISK MANAGEMENT
10 January 1994
SCHERING TO FUND ZONAGEN RESEARCH
10 January 1994
1992 SEES SMALLER COMPANY MERGERS
10 January 1994
NIZORAL TOPS SKIN DRUG LEAGUE IN 1992
10 January 1994
ANALYSTS FORECAST FDA YEAR-END APPROVALS
13 December 1993
BAYER AND HOECHST BACK DRUG SECTOR
13 December 1993
SCHERING AND MALLINCKRODT DEAL
6 December 1993
SCHERING SAYS DRUG BUSINESS WILL GROW
22 November 1993
EUROPEAN STOCK COMMENT
25 October 1993
CHIRON REASSURES ON BETASERON
25 October 1993
EUROPEAN STOCK COMMENT
25 October 1993
DRUG COs ADAPTING TO A CHANGING INDUSTRY
25 October 1993
HOECHST-ROUSSEL TO FIGHT COGNEX PATENT
11 October 1993
BIOTECH STOOCK VS CLINTON HEALTH REFORM
4 October 1993
ARES-SERONO WILL BENEFIT FROM MS MARKET
27 September 1993
BETASERON SUPPLIED BY LOTTERY
13 September 1993
BETASERON DISTRIBUTION
6 September 1993
CHIRON TO PRODUCE BETASERON
6 September 1993
SCHERING AG GETS ANALYSTS' UPGRADING
23 August 1993
EUROPEAN STOCK COMMENT
23 August 1993
EUROPEAN STOCK COMMENT
16 August 1993
SCHERING AGSHARES SOAR
16 August 1993
OTC STATUS FOR ORAL CONTRACEPTIVES?
16 August 1993
GOOD 1993 FIRST HALF FOR SCHERING AG
16 August 1993
EARNINGS CLIMB AT ROUsSEL UCLAF
9 August 1993
HOECHST/SCHERING AG AGROCHEM MERGER
19 July 1993
SCHERING AG ON THRESHOLD
12 July 1993
HOECHST QUITS GERMAN DRUG ASSOC
5 July 1993
SPLIT THREATENS GERMAN DRUG INDUSTRY ASSOC
21 June 1993
FDA PANEL BACKS BERLEX DRUGS
7 June 1993
GROWTH AHEAD ALTANA WITH REBOUND IN 1994
7 June 1993
SCHERING AG TO EXPAND PHARMA DIV
31 May 1993
GERMAN HEALTH REFORM: DID IT WORK ON NOT?
31 May 1993
SCHERING AGRO TALKS WITH HOECHST
17 May 1993
POOR PERFORMANCE BY SCHERING AG IN 1st QTR
10 May 1993
17% GROWTH FOR WORLD CONTRAST MEDIA MARKET
19 April 1993
OTC TAVIST SHOWS RAPID GROWTH
12 April 1993
PRICE FLEXIBILITY AND THE DRUG INDUSTRY
12 April 1993
FDA PANEL ENDORSES BERLEX' BETASERON
29 March 1993
SCHERING AG ISSUES WARNING FOR 1993
29 March 1993
NYCOMED TO EXPAND IMAGING R&D
15 March 1993
SIGNIFICANT MOVES BY PHARMA COS IN FT 500
1 March 1993
EUROPE STOCK COMMENT
22 February 1993
AGROCHEMICALS PULL SCHERING DOWN
22 February 1993
HAFSLUND NYCOMED "IN A STRONG GROWTH PHASE"
22 February 1993
NET PROFIT DOWN 4% AT SCHERING AG
15 February 1993
EUROPE STOCK COMMENT
8 February 1993
NEW CHEMICAL ENTITIES LAUNCHED IN 1992
1 February 1993
UK BLACKLIST and a "TWO-TIER" NHS
18 January 1993
SCHERING AG GENTECH IN USA
18 January 1993
SCHERING AG MOVES IN USA AND JAPAN
4 January 1993
GLOBAL DRUG MARKET: 30 YEARS OF GROWTH
4 January 1993
1992 SEES SMALLER COMPANY MERGERS
4 January 1993
SCHERING AG STILL SEEKING PARTNER
14 December 1992
HAFSLUND NYCOMED DOWNGRADED
7 December 1992
BERLEX' BETAPACE APPROVED
9 November 1992
MEIJI SEIKA R&D UPDATE
9 November 1992
SCHERING RETURNS TO RUSSIA
12 October 1992
CHEMICAL INSIGHT INDUSTRIAL RANKINGS
5 October 1992
CONTRAST MEDIA MARKET TO 2000
7 September 1992
1991 "BETTER THAN EXPECTED" AT SCHERING
22 June 1992
SCHERING AG PROFIT DECLINE FORECAST
15 June 1992
Stock Comment:SPECTRUM
15 June 1992
SYNTHELABO INTENDS TO UP INTERNATIONAL STATUS
25 May 1992
TLC CHAIRMAN LOOKS BACK ON 1991
18 May 1992
SOTALOL BEST, SAYS ARRHYTHMIA STUDY
27 April 1992
STRONG INCREASES IN 1991 AT BRISTOL-MYERS SQUIBB
20 April 1992
HAFSLUND GOES FOR ITALIAN MARKET
13 April 1992
STOCK MARKET COMMENTARY: EUROPE
20 January 1992
SCHERING AND ASTA TERMINATE ITALIAN JOINT VENTURE
20 January 1992
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
